Not Tagged
Not Tagged
['rectal']
de-escalation time! dr. deb schrag w/ prospect: neoadj folfox with selective chemort (if &lt;20% response) vs neoadj chemort for locally advanced rectal cancer. dfs 80.8 vs 78.6% hr 0.92, ci went to 1.14, lower than ni margin 1.29. #asco23 
Medical oncologist: GI cancers & cancer of unknown primary + high quality & value-based cancer care delivery. @UTexasValue MSHCT student. Tweets mine.